Target Name: COLQ
NCBI ID: G8292
Other Name(s): CMS5 | single strand of homotrimeric collagen-like tail subunit of asymmetric acetylcholinesterase | Acetylcholinesterase collagenic tail peptide | Acetylcholinesterase collagen-like tail subunit | Collagenic tail of endplate acetylcholinesterase | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | COLQ variant II | Acetylcholinesterase collagenic tail peptide (isoform III) | Acetylcholinesterase collagenic tail peptide (isoform II) | COLQ variant I | COLQ_HUMAN | Collagen like tail subunit of asymmetric acetylcholinesterase, transcript variant I | AChE Q subunit | collagen like tail subunit of asymmetric acetylcholinesterase | Acetylcholinesterase collagenic tail peptide (isoform I) | EAD | Collagen like tail subunit of asymmetric acetylcholinesterase, transcript variant II | Collagen like tail subunit of asymmetric acetylcholinesterase, transcript variant III | acetylcholinesterase-associated collagen | FLJ55041 | COLQ variant III | Single strand of homotrimeric collagen-like tail subunit of asymmetric acetylcholinesterase | collagenic tail of endplate acetylcholinesterase | OTTHUMP00000209566 | Acetylcholinesterase-associated collagen

A Promising Approach: COLQ as a Drug Target and Biomarker

Introduction

The discovery of new biomarkers and drug targets has always been a driving force in the pharmaceutical industry. One of the promising candidates in this field is ColQ, a protein that is expressed in various tissues of the human body. In this article, we will explore the potential of ColQ as a drug target and biomarker.

UnderstandingColQ

COLQ stands for colostrinin-like protein-5. It is a member of the integrin family, which is a group of proteins that play a critical role in cell-cell adhesion and tissue structure. COLQ is expressed in various tissues of the human body, including the skin, heart, kidneys, and intestine.

One of the unique features of COLQ is its potential as a drug target. Its protein structure and function have been extensively studied, providing valuable insights into its potential as a drug target.

The Potential of ColQ as a Drug Target

COLQ has been identified as a potential drug target due to its unique structure and function. The protein is composed of a pre-伪 chain and a post-伪 chain. The pre-伪 chain contains a unique N-terminal region that contains a conserved sequence known as Asp-219. This conserved sequence is involved in the formation of a salt bridge, which is critical for protein-protein interactions.

The post-伪 chain contains a unique C-terminal region that is involved in the formation of a hydrophobic core. This hydrophobic core is important for the protein's stability and functions as a drug target.

Additionally, COLQ has been shown to interact with several other proteins, including the transcription factor, NF-kappa-B, and the protein kinase, MAPK. These interactions suggest that COLQ may be a useful target for small molecules that can modulate its function.

The Potential of ColQ as a Biomarker

COLQ has also been identified as a potential biomarker due to its unique expression pattern. COLQ is expressed in various tissues of the human body, including the skin, heart, kidneys, and intestine. This makes it a potential biomarker for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.

One of the key advantages of COLQ as a biomarker is its potential to be non-invasive. Unlike many other biomarkers, COLQ does not require the use of a blood sample or other invasive procedures. This makes it a promising candidate for a variety of applications , including non-invasive diagnostic tests and monitoring therapies.

Conclusion

In conclusion, ColQ is a protein that has significant potential as a drug target and biomarker. Its unique structure and function, as well as its ability to interact with multiple proteins, make it an attractive candidate for drug development. As further research is conducted, we may see the discovery of new treatments for a variety of diseases.

Protein Name: Collagen Like Tail Subunit Of Asymmetric Acetylcholinesterase

Functions: Anchors the catalytic subunits of asymmetric AChE to the synaptic basal lamina

More Common Targets

COMETT | COMMD1 | COMMD10 | COMMD2 | COMMD3 | COMMD3-BMI1 | COMMD4 | COMMD5 | COMMD6 | COMMD7 | COMMD8 | COMMD9 | COMP | Complement Complex | Complement component 1q | Complement component C1 | Complement component C8 | COMT | COMTD1 | Condensin complex | Condensin-2 complex | Conserved oligomeric Golgi complex | COP1 | COP9 signalosome complex | COPA | COPB1 | COPB2 | COPB2-DT | COPE | COPG1 | COPG2 | COPG2IT1 | COPRS | COPS2 | COPS3 | COPS4 | COPS5 | COPS6 | COPS7A | COPS7B | COPS8 | COPS8P3 | COPS9 | COPZ1 | COPZ2 | COQ10A | COQ10B | COQ2 | COQ3 | COQ4 | COQ5 | COQ6 | COQ7 | COQ8A | COQ8B | COQ9 | CORIN | CORO1A | CORO1B | CORO1C | CORO2A | CORO2B | CORO6 | CORO7 | CORT | Corticotropin-Releasing Factor (CRF) Receptor | COTL1 | COTL1P1 | COX1 | COX10 | COX10-DT | COX11 | COX14 | COX15 | COX16 | COX17 | COX18 | COX19 | COX2 | COX20 | COX3 | COX4I1 | COX4I1P1 | COX4I2 | COX5A | COX5B | COX6A1 | COX6A2 | COX6B1 | COX6B1P2 | COX6B1P3 | COX6B1P5 | COX6B1P7 | COX6B2 | COX6C | COX6CP1 | COX6CP17 | COX7A1 | COX7A2 | COX7A2L